国立卫生研究院即将发起一项新的大型治疗性疫苗试验,用以检验一种名为Remune的疫苗是否能够阻止HIV感染者发展成为成熟期的艾滋病。 Remune疫苗是由位于加州卡尔斯巴德的免疫反应公司利用几乎完整的灭活HIV方法制造出来的,研究者期望该疫苗能够通过激活患者的免疫系统,将病毒保持在较低水平,防止正在接受药物治疗的患者出现病情反复,最终使患者停药,从而克服病毒的耐药性。因为以往的研究表明,尽管抗病毒 The National Institutes of Health is about to launch a new large-scale therapeutic vaccine trial to test whether a vaccine called Remune can prevent HIV-infected people from developing into mature AIDS. The Remune vaccine was manufactured by an immune response company based in Carlsbad, Calif., Using a nearly complete inactivated HIV approach. The researchers expected the vaccine to be able to keep the virus low by activating the patient’s immune system, preventing it from being accepted Drug treatment in patients with recurrent disease, the final patient withdrawal, thus overcoming the virus resistance. Because previous studies have shown that despite antivirals